Physician profile
Edward Terrien
NPI 1013928910
$49,833.89
in general payments reported to CMS, 2019-2025
22 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $375 · 2021: $5,056 · 2022: $2,638 · 2023: $15K · 2024: $5,967 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $3,932 · Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,850.00 |
| Travel and Lodging | $3,932.24 |
| Food and Beverage | $2,412.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,371.10 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $20,944.68 | 2019-2020 | |
| Penumbra, INC. | $2,400.00 | 2021 | |
| Boston Scientific Corporation | $1,380.92 | 2023-2024 | Resonate El Icd Vr, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $425.19 | 2022-2025 | Coroflow, Mitraclip, Triclip |
| Inari Medical, INC. | $293.62 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $268.84 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $206.86 | 2022-2025 | Impella |
| Heartflow, INC. | $90.25 | 2024 | |
| Lantheus Medical Imaging, INC. | $86.93 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.88 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $85.33 | 2022-2023 | Farxiga |
| Pfizer INC. | $41.64 | 2023 | |
| Recor Medical INC | $23.30 | 2024 | Paradise Renal Denervation System |
| Cardiva Medical, INC. | $19.64 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.95 | 2023 | Verquvo |
| Edwards Lifesciences Corporation | $16.81 | 2025 | Sapien 3 Ultra Resilia |
| Solventum Corporation | $16.58 | 2025 | Activ.A.C., Promogran Prisma |
| Amgen INC. | $16.58 | 2023 | Repatha |
| Veryan Medical Incorporated | $14.77 | 2023 | Biomimics 3d Vascular Stent System |
| Cardiovascular Systems INC. | $12.94 | 2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Terrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.